STRS Ohio’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

STRS Ohio’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-20,100	Closed	-$40K	–	2127
2022 Q2	$40K	Hold	20,100	–	–	﹤0.01%	1891
2022 Q1	$46K	Hold	20,100	–	–	﹤0.01%	1958
2021 Q4	$93K	Sell	20,100 -13,500	-40%	-$83.8K	﹤0.01%	1911
2021 Q3	$256K	Buy	33,600 +28,900	+615%	+$245K	﹤0.01%	1703
2021 Q2	$45K	Buy	+4,700	New	+$37.4K	﹤0.01%	2124
2018 Q4	–	Sell	-46,500	Closed	-$204K	–	2162
2018 Q3	$204K	Hold	46,500	–	–	﹤0.01%	1711
2018 Q2	$334K	Buy	+46,500	New	+$316K	﹤0.01%	1576
2015 Q3	–	Sell	-9,100	Closed	-$145K	–	1958
2015 Q2	$160K	Buy	+9,100	New	+$117K	﹤0.01%	1609

Other funds holding SRNE

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

STRS Ohio's SRNE Position: Q3 2022 in Review

STRS Ohio sold out of Sorrento Therapeutics, Inc. (SRNE) in Q3 2022, closing a stake of 20,100 shares — an estimated $40K sold.

STRS Ohio first reported a position in SRNE in Q2 2015 and held it in 8 quarters. The position peaked at $334K in Q2 2018. 233 funds tracked by Wall St. Rank hold SRNE as of Q3 2022.

STRS Ohio reported no remaining Sorrento Therapeutics, Inc. position as of Q3 2022 after selling out during the quarter.
STRS Ohio sold 20,100 Sorrento Therapeutics, Inc. shares in Q3 2022, an estimated $40K.
STRS Ohio first reported a position in Sorrento Therapeutics, Inc. in Q2 2015 and held it in 8 quarters.
STRS Ohio's Sorrento Therapeutics, Inc. position peaked at $334K in Q2 2018.
233 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q3 2022.

Based on STRS Ohio's 13F filing for Q3 2022, filed 27 Oct 2022.